Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Oligoprogressive 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Carcinoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Patients 1

Interventions

Fluorouracil 498 Bevacizumab 476 Oxaliplatin 450 Leucovorin 442 Irinotecan 408 Cetuximab 318 Capecitabine 317 pembrolizumab 142 Folfox protocol 128 Panitumumab 117 regorafenib 105 Colonoscopy 88 Nivolumab 82 IFL protocol 81 Drug Therapy 77 trifluridine tipiracil drug combination 73 Radiotherapy 66 HMPL-013 65 Blood Specimen Collection 52 Gemcitabine 49 Specimen Handling 47 Standard of Care 45 Neoadjuvant Therapy 45 Magnetic Resonance Spectroscopy 44 Biopsy 44 Chemotherapy, Adjuvant 41 Trifluridine 40 atezolizumab 39 Cyclophosphamide 39 Surveys and Questionnaires 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × DEAE-Dextran × Clear all

NCT07403877 2026-02-11

TORCH-OPTIMA

Fudan University

Phase 2 Not yet recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡